These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 13567917)
1. The neuroleptic action and effectiveness of proclorperazine in psychiatric disorders. FREYHAN FA Psychiatr Res Rep Am Psychiatr Assoc; 1958 Mar; 9():32-45. PubMed ID: 13567917 [No Abstract] [Full Text] [Related]
2. [Experimental neurological syndromes and psychiatric therapy. II. Psychic and therapeutic effects of a new major neuroleptic, 7843 RP; polygraphic study]. DELAY J; DENIKER P; ROPERT R; BEEK H; BARANDE R; EURIEULT M Presse Med (1893); 1959 Jan; 67(6):201-3. PubMed ID: 13633845 [No Abstract] [Full Text] [Related]
3. Treatment of psychiatric disorders in mental defectives with perphenazine. SPROGIS GR; BABCOCK SD; SEGALL J J Med Soc N J; 1958 Mar; 55(3):120-3. PubMed ID: 13514429 [No Abstract] [Full Text] [Related]
4. [New neuroleptic drug in psychiatry, 8-acetyl-10-(3-dimethylaminopropyl)phenothiazine maleate (CB-1522)]. DELAY J; PICHOT P; ROPERT R Presse Med (1893); 1957 Mar; 65(22):491-3. PubMed ID: 13431756 [No Abstract] [Full Text] [Related]
5. Prochlorperazine in hospitalized and private psychiatric patients. WILCOX F Dis Nerv Syst; 1958 Mar; 19(3):118-21. PubMed ID: 13524118 [No Abstract] [Full Text] [Related]
6. Treatment of ambulatory and hospitalized psychiatric patients with trilafon. AYD FJ Dis Nerv Syst; 1957 Oct; 18(10):394-7. PubMed ID: 13473680 [No Abstract] [Full Text] [Related]
7. [Notes on the use of a new phenothiazine derivative, perphenazine, in neuro-psychiatric practice]. LARICCHIA R; BASEVI A Minerva Med; 1958 May; 49(39, Suppl.):1993-5. PubMed ID: 13565614 [No Abstract] [Full Text] [Related]
8. [Effect of placebos in a psychiatric observation war as demonstrated by a clinical trial of a new phenothiazine derivative]. LEHMANN H; RETTERSTOL N; SIRNES T Tidsskr Nor Laegeforen; 1958 Jun; 78(12):588-92. PubMed ID: 13569456 [No Abstract] [Full Text] [Related]
9. Clinical efficacy of proclorperazine (compazine) in mental illness. RIESENMAN FR; PETTIT MB Am J Psychiatry; 1959 May; 115(11):1032-3. PubMed ID: 13637287 [No Abstract] [Full Text] [Related]
10. [Ist results in the use, in psychiatric therapy, of a new neuroleptic drug: thioidazine (Melleril)]. CASI A; LOMBARDI M; MARZOTTI P Rass Studi Psichiatr; 1961; 50():472-80. PubMed ID: 13691284 [No Abstract] [Full Text] [Related]
11. The neurobiology of Meditation and its clinical effectiveness in psychiatric disorders. Rubia K Biol Psychol; 2009 Sep; 82(1):1-11. PubMed ID: 19393712 [TBL] [Abstract][Full Text] [Related]
12. Effects of promazine in mental syndromes. AZIMA H; DUROST H Can Med Assoc J; 1957 Mar; 76(6):442-6. PubMed ID: 13413759 [No Abstract] [Full Text] [Related]
13. Studies on the use of promazine in acute and chronic nervous and mental disturbances. BURDINE WE; SHIPLEY TE; PAPAS AT J Med Assoc Ga; 1957 Apr; 46(4):171-3. PubMed ID: 13416819 [No Abstract] [Full Text] [Related]
14. [Notes on liver function test in mental patients treated with promazine]. PARDERA G Riv Patol Nerv Ment; 1957; 78(3):1106-8. PubMed ID: 13528805 [No Abstract] [Full Text] [Related]
15. Changes in the electroencephalogram caused by intravenous perphenazine in normal subjects and mental disease patients; preliminary note. NEGRI VU; BASEVI A Minerva Med; 1958 May; 49(39, Suppl.):1995-9. PubMed ID: 13565615 [No Abstract] [Full Text] [Related]
16. [Long-term treatment of mental disorders with high doses of phenothiazines]. van PAASSEN ; RONNER HJ Ned Tijdschr Geneeskd; 1959 Oct; 103():2201-3. PubMed ID: 14429630 [No Abstract] [Full Text] [Related]